DXC

1.00%

$3.03 dexus convenience retail reit

Ann: FY23 Results presentation, page-4

First 4 Last

Share
Profile

Follow
rogerthedog

377 Posts.

229

24/08/23

08:43

Post #: 69516051
Share

Originally posted by timbowls: ↑

I had a 45 minute zoom call with the fund manager yesterday which was very informative on what the path for DXC might look like going forward. The main takeaways that I took out of it were:

- There is likely to be further cap rate expansion at the next set of results but I'd expect this will be relatively minimal considering there is evidence of recent petrol station freeholds changing hands around that 6.1 percent mark that DXC has them on the books at

- Management intends to continue selling assets and repaying debt until the gearing is under 30 percent. In around 12 months time they expect the cycle to turn and for DXC to be in a strong financial position to either purchase assets in the convenience class that may not be petrol stations (I suggested fast food freeholds however the manager pointed out that these tend to change hands on very low yields which is quite correct). Management also expect there to be consolidation in the REIT space around this time too.

- I pointed out that I would have liked to have seen more open discussion of the significant NTA gap in the last few presentations

- The company is currently covered by 4 brokers (Ord Minnett, Moelis, Evans and Partners and Morgans) with three of those currently sitting at a buy recommendation and the 4th being an accumulate. The highest target price is $3.40 and the lowest is $3. They kindly provided me copies of all 4 reports so I would be happy to share with any other interested holders.

I came away from the meeting feeling like DXC have a very clear strategy that they are executing on it's just not being appreciated by the market.

Expand

Thanks for that. Appreciate the update.

DXC Price at posting: $2.50 Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 24 more messages in this thread...

First 4 Last

Add DXC (ASX) to my watchlist

(20min delay)
Last $3.03		Change 0.030(1.00%)		Mkt cap ! $417.4M

Open	High	Low	Value	Volume
$3.03	$3.05	$2.99	$371.7K	122.5K

Buyers (Bids)

No.	Vol.	Price($)
3	18558	$3.01

Sellers (Offers)

Price($)	Vol.	No.
$3.05	13338	3

View Market Depth

No.	Vol.	Price($)
2	17190	3.010
1	13526	3.000
2	11335	2.980
2	15670	2.970
1	10000	2.960

Price($)	Vol.	No.
3.050	11970	2
3.060	10384	2
3.090	5763	1
3.100	500	1
3.120	1300	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

DXC (ASX) Chart

Ann: FY23 Results presentation, page-4

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: FY23 Results presentation, page-4

Top Stories

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News